FDMT Company Profile and Key Details

Q: Who are the executives of FDMT?

Dr. An Song Ph.D.Chief Devel. OfficerMs. Theresa JankeCo-Founder & Chief of StaffDr. David H. Kirn M.D.Co-Founder, Chief Executive Officer & DirectorDr. Robert S. FishmanChief Medical Officer & Therapeutic Area Head of PulmonologyMr. August J. Moretti Esq., J.D.Chief Financial OfficerDr. Fred Kamal Ph.D.Pres & Chief Operating OfficerDr. Raphael Schiffmann M.D.Senior Vice President & Therapeutic Area Head of CardiologyDr. Robert Y. Kim M.B.A., M.D.Chief Medical OfficerDr. Fariborz Kamal Ph.D.Pres & Chief Operating OfficerDr. John F. Milligan Ph.D.Executive ChairmanMike ZanoniVice President of Investor RelationsDr. Scott P. Bizily J.D., Ph.D.Chief Legal & HR Officer and Corporation Sec.Ms. Karen S. CarothersController

NASDAQ : FDMT

4D Molecular Therapeutics

$11.30

-1.01-8.21%

At Close 4:00 PM

60.74

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

4D Molecular Therapeutics, Inc. (FDMT) stock declined over -8.20%, trading at $11.30 on NASDAQ, down from the previous close of $12.31. The stock opened at $12.11, fluctuating between $11.24 and $12.11 in the recent session.

Stock Snapshot

12.31

Prev. Close

590.72M

Market Cap

11.235

Day Low

-4.4

P/E Ratio

-2.57

EPS (TTM)

Cash Flow per Share

12.11

Open

52.28M

Number of Shares

12.11

Day High

91.26%

Free Float in %

0.01

Book Value

629.53K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jul 13, 2026	12.12	12.12	11.23	11.30	631.2K
Jul 10, 2026	13.01	13.01	11.57	12.31	683.56K
Jul 09, 2026	13.02	13.36	12.68	12.89	642.11K
Jul 08, 2026	12.71	13.39	12.30	13.02	757.16K
Jul 07, 2026	12.80	12.94	12.33	12.82	650.25K
Jul 06, 2026	13.00	13.20	12.71	12.72	873.62K
Jul 02, 2026	12.87	13.40	12.63	13.00	1M
Jul 01, 2026	13.25	13.53	12.57	12.69	1.07M
Jun 30, 2026	12.86	14.00	12.69	13.30	2.8M
Jun 29, 2026	11.68	13.33	11.68	12.88	1.52M
Jun 26, 2026	11.49	12.04	10.85	11.60	2.02M
Jun 25, 2026	11.65	12.05	11.30	11.52	984.93K
Jun 24, 2026	11.65	11.81	11.32	11.62	1.05M
Jun 23, 2026	10.22	12.18	10.22	11.60	2.07M
Jun 22, 2026	9.82	10.89	9.75	10.42	1.7M
Jun 18, 2026	9.72	9.97	9.45	9.66	892.22K
Jun 17, 2026	8.80	9.87	8.73	9.42	962.79K
Jun 16, 2026	9.20	9.23	8.55	8.67	748.37K
Jun 15, 2026	9.04	9.80	8.96	9.22	1.06M
Jun 12, 2026	9.00	9.38	8.83	8.83	560.17K

Contact Details

EmeryVille, CA 94608

United States

https://www.4dmoleculartherapeutics.com 510 505 2680

About Company

4D Molecular Therapeutics, Inc. is a clinical-stage gene therapy company that engineers therapeutic agents by leveraging its proprietary adeno-associated virus (AAV) vector technology. The company's developmental efforts are concentrated across a trio of therapeutic fields: ophthalmology (eye conditions), cardiology (heart ailments), and pulmonology (respiratory disorders). Within its active pipeline, three specific product candidates have advanced into clinical trial phases, all currently undergoing Phase 1/2 clinical assessment: 4D-125 is being evaluated for the treatment of X-linked retinitis pigmentosa. 4D-110 targets choroideremia. 4D-310 is focused on addressing Fabry disease. Beyond these, two Investigational New Drug (IND) candidates are in development: 4D-150, aimed at combating wet age-related macular degeneration, and 4D-710, designed to tackle cystic fibrosis lung disease. To advance its mission, 4D Molecular Therapeutics, Inc. actively engages in research and development partnerships with entities such as uniQure, CRF, Roche, and CFF. The firm commenced operations in 2013 and maintains its headquarters in Emeryville, California.

Stock Peers

ARGX

-1.37-0.16%

argenx SE$876.25 REGN

-1.43-0.22%

Regeneron Pharmaceuticals, Inc.$663.09 UTHR

-11.49-2.10%

United Therapeutics Corporation$535.57 MDGL

-5.7-1.06%

Madrigal Pharmaceuticals, Inc.$531.00 VRTX

-5.14-1.06%

Vertex Pharmaceuticals Incorporated$480.25 KRYS

-2.37-0.65%

Krystal Biotech, Inc.$363.44 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-10.43-3.21%

Praxis Precision Medicines, Inc.$314.56 LGND

-6.99-2.21%

Ligand Pharmaceuticals Incorporated$309.25 ONC

5.26001+1.76%

BeOne Medicines AG$303.96

Frequently Asked Questions

What is the current 4D Molecular Therapeutics, Inc. (FDMT) stock price?

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) stock price is $11.30 in the last trading session. During the trading session, FDMT stock reached the peak price of $12.11 while $11.24 was the lowest point it dropped to. The percentage change in FDMT stock occurred in the recent session was -8.2% while the dollar amount for the price change in FDMT stock was - $1.01.

FDMT's industry and sector of operation?

The NASDAQ listed FDMT is part of Biotechnology industry that operates in the broader Healthcare sector. 4D Molecular Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of FDMT?

Dr. An Song Ph.D.
Chief Devel. Officer
Ms. Theresa Janke
Co-Founder & Chief of Staff
Dr. David H. Kirn M.D.
Co-Founder, Chief Executive Officer & Director
Dr. Robert S. Fishman
Chief Medical Officer & Therapeutic Area Head of Pulmonology
Mr. August J. Moretti Esq., J.D.
Chief Financial Officer
Dr. Fred Kamal Ph.D.
Pres & Chief Operating Officer
Dr. Raphael Schiffmann M.D.
Senior Vice President & Therapeutic Area Head of Cardiology
Dr. Robert Y. Kim M.B.A., M.D.
Chief Medical Officer
Dr. Fariborz Kamal Ph.D.
Pres & Chief Operating Officer
Dr. John F. Milligan Ph.D.
Executive Chairman
Mike Zanoni
Vice President of Investor Relations
Dr. Scott P. Bizily J.D., Ph.D.
Chief Legal & HR Officer and Corporation Sec.
Ms. Karen S. Carothers
Controller

How FDMT did perform over past 52-week?

FDMT's closing price is 174.94% higher than its 52-week low of $4.11 where as its distance from 52-week high of $14.00 is -19.29%.

How many employees does FDMT have?

Number of FDMT employees currently stands at 227.

Link for FDMT official website?

Official Website of FDMT is: https://www.4dmoleculartherapeutics.com

How do I contact FDMT?

FDMT could be contacted at phone 510 505 2680 and can also be accessed through its website. FDMT operates from 5858 Horton Street, EmeryVille, CA 94608, United States.

How many shares of FDMT are traded daily?

FDMT stock volume for the day was 629.53K shares. The average number of FDMT shares traded daily for last 3 months was 872.77K.

What is the market cap of FDMT currently?

The market value of FDMT currently stands at $590.72M with its latest stock price at $11.30 and 52.28M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	227
Beta	2.69
Sales or Revenue	$20.72M
5Y Sales Change%	-0.531%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	227
Beta	2.69
Sales or Revenue	$20.72M
5Y Sales Change%	-0.531%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

FDMT Company Profile and Key Details

4D Molecular Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Company Overview

Earnings & Analyst Outlook

Valuation Metrics

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways